Novel treatments for neurodegenerative conditions

 Multi-modal, disease-modifying therapies


NeuroBo is a clinical-stage biopharmaceutical company with two drug programs to impact a range of indications in neurodegenerative disease.



NeuroBo Pharmaceuticals was jointly founded by JK BioPharma Solutions, a company specializing in the development of new biopharmaceuticals, and Dr. Roy Freeman, a Harvard Medical School neurologist.

The NeuroBo team hails from various organizations within the pharmaceutical, diabetes, and biotech industries, yet the NeuroBo team has one shared goal: to bring life-changing and disease-modifying therapies to patients suffering from neurodegenerative diseases worldwide.  

With John L. Brooks III, a well-known executive within the life sciences industry, at the helm of the company, along with Dr. Mark Versavel, experienced senior clinical drug developer and clinical pharmacologist, and Dr. Nandan Padukone, a well-known biotech executive, NeuroBo is poised to revolutionize the way we approach treatments for neurodegenerative diseases.